
AKBA
USDAkebia Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$2.100
High
$2.145
Low
$2.070
Volume
4.47M
Company Fundamentals
Market Cap
563.4M
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
4.04M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Akebia Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
HC Wainwright & Co. Maintains Buy on Akebia Therapeutics, Lowers Price Target to $6
HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics with a Buy and lowers the price target from $8 to $6.
BTIG Maintains Buy on Akebia Therapeutics, Lowers Price Target to $5
BTIG analyst Julian Harrison maintains Akebia Therapeutics with a Buy and lowers the price target from $10 to $5.
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
Related Stocks
NXT
Nextracker Inc.
VOC
VOC Energy Trust Units of Beneficial Interest
MGRB
Affiliated Managers Group Inc. 4.750% Junior Subordinated Notes due 2060
HVT
Haverty Furniture Companies Inc.
SACH
Sachem Capital Corp. Common Shares
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.